CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 465321-465495 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T65091","span":{"begin":0,"end":174},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Oral, once-daily roflumilast exhibits no direct or acute bronchodilatory activity in patients with mild to moderate asthma as could be achieved with short-acting 2 -agonists."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T147","span":{"begin":0,"end":174},"obj":"Sentence"}],"text":"Oral, once-daily roflumilast exhibits no direct or acute bronchodilatory activity in patients with mild to moderate asthma as could be achieved with short-acting 2 -agonists."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4609","span":{"begin":116,"end":122},"obj":"Disease"}],"attributes":[{"id":"A4609","pred":"mondo_id","subj":"T4609","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"}],"text":"Oral, once-daily roflumilast exhibits no direct or acute bronchodilatory activity in patients with mild to moderate asthma as could be achieved with short-acting 2 -agonists."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T2539","span":{"begin":116,"end":122},"obj":"Phenotype"}],"attributes":[{"id":"A2539","pred":"hp_id","subj":"T2539","obj":"http://purl.obolibrary.org/obo/HP_0002099"}],"text":"Oral, once-daily roflumilast exhibits no direct or acute bronchodilatory activity in patients with mild to moderate asthma as could be achieved with short-acting 2 -agonists."}